Literature DB >> 12503888

The added value of embryo cryopreservation to cumulative ongoing pregnancy rates per IVF treatment: is cryopreservation worth the effort?

D de Jong1, M J C Eijkemans, N G M Beckers, R V Pruijsten, B C J M Fauser, N S Macklon.   

Abstract

PURPOSE: To calculate the added benefit of a cryopreservation program to the cumulative ongoing pregnancy rate over a maximum of three cycles of IVF.
METHODS: A total of 1251 couples beginning their first IVF treatment between January 1995 and December 1999 were evaluated. Ongoing pregnancies from fresh and subsequent cryopreserved embryo transfer cycles were analyzed. Pregnancies arising from the cryopreservation cycle were considered to augment the cumulative pregnancy rate when no ongoing pregnancy arose from the fresh embryo transfer cycle.
RESULTS: The ongoing pregnancy rate per cryopreserved embryo transfer was 11.7%. The cumulative ongoing pregnancy rate following three successive started fresh IVF cycles was 42.5%. When pregnancies arising from the transfer of thawed cryopreserved embryos were included, the cumulative ongoing pregnancy rate increased to 43.8%, rising to 44.8% when extrapolated data from as yet unthawed embryos was included.
CONCLUSIONS: When analyzed in these terms, the supplementary benefit of cryopreserving supranumerical embryos appears limited.

Entities:  

Mesh:

Year:  2002        PMID: 12503888      PMCID: PMC3455830          DOI: 10.1023/a:1021211115337

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  42 in total

1.  Assisted reproductive technology in Europe, 1997. Results generated from European registers by ESHRE. European IVF-Monitoring Programme (EIM), for the European Society of Human Reproduction and Embryology (ESHRE).

Authors:  K G Nygren; A N Andersen
Journal:  Hum Reprod       Date:  2001-02       Impact factor: 6.918

2.  Zona pellucida damage to human embryos after cryopreservation and the consequences for their blastomere survival and in-vitro viability.

Authors:  E Van Den Abbeel; A Van Steirteghem
Journal:  Hum Reprod       Date:  2000-02       Impact factor: 6.918

3.  A quantitative analysis of the impact of cryopreservation on the implantation potential of human early cleavage stage embryos.

Authors:  D H Edgar; H Bourne; A L Speirs; J C McBain
Journal:  Hum Reprod       Date:  2000-01       Impact factor: 6.918

Review 4.  Assisted reproductive technology in the United States: 1997 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry.

Authors: 
Journal:  Fertil Steril       Date:  2000-10       Impact factor: 7.329

5.  Implantation rates after in vitro fertilization and transfer of a maximum of two embryos that have undergone three to five days of culture.

Authors:  G J Huisman; B C Fauser; M J Eijkemans; M H Pieters
Journal:  Fertil Steril       Date:  2000-01       Impact factor: 7.329

6.  Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group.

Authors:  G Borm; B Mannaerts
Journal:  Hum Reprod       Date:  2000-07       Impact factor: 6.918

7.  Live-birth rates and multiple-birth risk using in vitro fertilization.

Authors:  L A Schieve; H B Peterson; S F Meikle; G Jeng; I Danel; N M Burnett; L S Wilcox
Journal:  JAMA       Date:  1999-11-17       Impact factor: 56.272

8.  A pilot study involving minimal ovarian stimulation for in vitro fertilization: extending the "follicle-stimulating hormone window" combined with the gonadotropin-releasing hormone antagonist cetrorelix.

Authors:  D de Jong; N S Macklon; B C Fauser
Journal:  Fertil Steril       Date:  2000-05       Impact factor: 7.329

9.  Friendly IVF: patient opinions.

Authors:  A Højgaard; H J Ingerslev; J Dinesen
Journal:  Hum Reprod       Date:  2001-07       Impact factor: 6.918

10.  Clinical status of human embryo cryopreservation in the United States of America.

Authors:  E F Fugger
Journal:  Fertil Steril       Date:  1989-12       Impact factor: 7.329

View more
  4 in total

Review 1.  Breast cancer: an update on treatment-related infertility.

Authors:  Erica Silvestris; Miriam Dellino; Paola Cafforio; Angelo Virgilio Paradiso; Gennaro Cormio; Stella D'Oronzo
Journal:  J Cancer Res Clin Oncol       Date:  2020-01-31       Impact factor: 4.553

2.  Natural selection of human embryos: decidualizing endometrial stromal cells serve as sensors of embryo quality upon implantation.

Authors:  Gijs Teklenburg; Madhuri Salker; Mariam Molokhia; Stuart Lavery; Geoffrey Trew; Tepchongchit Aojanepong; Helen J Mardon; Amali U Lokugamage; Raj Rai; Christian Landles; Bernard A J Roelen; Siobhan Quenby; Ewart W Kuijk; Annemieke Kavelaars; Cobi J Heijnen; Lesley Regan; Jan J Brosens; Nick S Macklon
Journal:  PLoS One       Date:  2010-04-21       Impact factor: 3.240

3.  Cell lineage specific distribution of H3K27 trimethylation accumulation in an in vitro model for human implantation.

Authors:  Gijs Teklenburg; Charlotte H E Weimar; Bart C J M Fauser; Nick Macklon; Niels Geijsen; Cobi J Heijnen; Susana M Chuva de Sousa Lopes; Ewart W Kuijk
Journal:  PLoS One       Date:  2012-03-07       Impact factor: 3.240

Review 4.  Cryopreservation of embryos and oocytes in human assisted reproduction.

Authors:  János Konc; Katalin Kanyó; Rita Kriston; Bence Somoskői; Sándor Cseh
Journal:  Biomed Res Int       Date:  2014-03-23       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.